Results 101 to 110 of about 45,281 (217)

The impact of Transcranial Magnetic Stimulation (TMS) on seizure course in people with and without epilepsy. [PDF]

Clin Neurophysiol Pract, 2022
Pang S, D'Ambrosio S, Battaglia G, Jiménez-Jiménez D, Perulli M, Silvennoinen K, Zagaglia S, Sisodiya SM, Balestrini S.   +8 more
europepmc   +1 more source

Movement Disorders in Neuromyelitis Optica Spectrum Disorder: A Systematic Review

Movement Disorders Clinical Practice, Volume 13, Issue 3, Page 600-610, March 2026.
Abstract Background Several movement disorders (MD) have been reported to occur in neuromyelitis optica spectrum disorder (NMOSD). No extensive review has addressed the whole spectrum of MD in NMOSD. Objective This article aims to review MD in NMOSD, describing its prevalence and features.
Luciana A.F. Bringel, Pedro L.G.S.B. Lima, Pedro V.F. Rodrigues, Francisco L.H.B. Cavalcante, Amanda R. Pinheiro, Fabricia M.S. Saraiva, Cynthia P. Rodrigues, Paulo V.S. Gonçalves, Leonardo J.R.A. Melo, Antônio E. Camelo‐Filho, Avelino M. Dutra‐Junior, Samuel R.O. Veras, Fernanda M.M. Carvalho, Flávia P.S. Rolim, Gabriela J. Martins, José A.C. D'Almeida, Pedro Braga‐Neto, Milena S. Pitombeira, Paulo R. Nobrega   +18 more
wiley   +1 more source

Is Dysphagia in Multiple System Atrophy Responsive to Levodopa? Results from a Retrospective Study

Movement Disorders Clinical Practice, Volume 13, Issue 3, Page 683-691, March 2026.
Abstract Background Dysphagia remains a major clinical concern in multiple system atrophy (MSA), and so far, lacks relevant treatment options. Objective To systematically assess levodopa‐responsiveness of dysphagia in MSA. Methods 19 MSA‐patients underwent endoscopic swallowing evaluation in Off‐ and On‐state, following an adapted FEES‐levodopa‐test ...
Florin Gandor, Luise Berger, Vera Jäger, Katharina Demmin, Doreen Gruber, Katja Schimming, Paulina Thimm, Georg Ebersbach, Stefanie Schreiber, Dominic Rowe, Annemarie Vogel   +10 more
wiley   +1 more source

EEG synchronized left prefrontal transcranial magnetic stimulation (TMS) for treatment resistant depression is feasible and produces an entrainment dependent clinical response: A randomized controlled double blind clinical trial. [PDF]

Brain Stimul, 2023
George MS, Huffman S, Doose J, Sun X, Dancy M, Faller J, Li X, Yuan H, Goldman RI, Sajda P, Brown TR.   +10 more
europepmc   +1 more source

Anticholinergic Burden and Botulinum Toxin Needs after Deep Brain Stimulation in Adult and Pediatric Patients with Dystonia

Movement Disorders Clinical Practice, Volume 13, Issue 3, Page 774-778, March 2026.
Abstract Background Anticholinergic medications and botulinum neurotoxin injections are established treatments for dystonia, yet they carry potential side effects and practical challenges. Deep brain stimulation (DBS) is offered in case of poor response to these approaches.
Marcela A. Montiel, Alessandro Magliozzi, Wei Kang Lim, Carolina Gorodetsky, George M. Ibrahim, Alfonso Fasano   +5 more
wiley   +1 more source

The efficacy of transcranial magnetic stimulation (TMS) for negative symptoms in schizophrenia: a systematic review and meta-analysis. [PDF]

Schizophrenia (Heidelb), 2022
Lorentzen R, Nguyen TD, McGirr A, Hieronymus F, Østergaard SD.   +4 more
europepmc   +1 more source

Test-Retest Reliability and Agreement of Single Pulse Transcranial Magnetic Stimulation (TMS) for Measuring Activity in Motor Cortex in Patients With Acute Ischemic Stroke. [PDF]

Neurosci Insights, 2022
Henriette B, Marianne N, Rønne PJ, Glavin KM, Wesenberg KT, Thorgaard SS, Troels W.   +6 more
europepmc   +1 more source

Huntington's Disease and Huntington's Disease‐like 2 (HDL2) in Martinique

Movement Disorders Clinical Practice, Volume 13, Issue 3, Page 673-682, March 2026.
ABSTRACT Background Huntington's Disease‐like 2 (HDL2), caused by a CAG repeat expansion in JPH3, closely resembles HD. All reported HDL2 patients to date have some African ancestry. While both disorders exist in the Caribbean, their relative frequency and clinical characteristics remain largely unknown.
Ignacio Antolin‐Sanfeliz, Anna‐Gaelle Giguet‐Valard, Sophie Duclos, Cécile Cazeneuve, Chloé Angelini, Aïssatou Signaté, Russell L. Margolis, Cyril Goizet, Rémi Bellance   +8 more
wiley   +1 more source

A visual and narrative timeline of US FDA milestones for Transcranial Magnetic Stimulation (TMS) devices. [PDF]

Brain Stimul, 2022
Cohen SL, Bikson M, Badran BW, George MS.   +3 more
europepmc   +1 more source

Segmental and Multifocal Isolated Dystonias: Similarities and Differences

Movement Disorders Clinical Practice, Volume 13, Issue 3, Page 748-756, March 2026.
Abstract Background Whether the traditional distinction between segmental and multifocal dystonia is clinically or scientifically useful remains unclear. Objective To evaluate whether idiopathic isolated adult‐onset segmental and multifocal dystonia can be differentiated based on clinical features other than the contiguity of affected body regions ...
Hyder A. Jinnah, Vittorio Velucci, Daniele Belvisi, Gamze Kilic‐Berkmen, Joel S. Perlmutter, Laura J. Wright, Christine Klein, Jeanne S. Feuerstein, Steven Bellows, Joseph Jankovic, Cynthia Comella, Richard L. Barbano, Aparna Wagle Shukla, Stephen G. Reich, Mark S. LeDoux, Alberto J. Espay, Kevin R. Duque, Florence C.F. Chang, Victor S.C. Fung, Sarah Pirio‐Richardson, Carmen Terranova, Emile S. Moukheiber, Sarah Idrissi, Barbara Vitucci, Susan H. Fox, Samuel Frank, Natividad Stover, Brian D. Berman, Rachel Saunders‐Pullman, William G. Ondo, Christopher L. Groth, Marcello Esposito, Laura Avanzino, Francesco Bono, Roberto Erro, Marcello Mario Mascia, Antonella Muroni, Alfredo Berardelli, Giovanni Defazio   +38 more
wiley   +1 more source